Page last updated: 2024-08-24

fluorexon and Malignant Melanoma

fluorexon has been researched along with Malignant Melanoma in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Caramalho, I; Faroudi, M; Müller, S; Padovan, E; Valitutti, S1
Berger, W; Elbling, L; Hauptmann, E; Kokoschka, EM; Micksche, M; Vetterlein, M1

Other Studies

2 other study(ies) available for fluorexon and Malignant Melanoma

ArticleYear
Visualizing CTL/melanoma cell interactions: multiple hits must be delivered for tumour cell annihilation.
    Journal of cellular and molecular medicine, 2009, Volume: 13, Issue:9B

    Topics: Apoptosis; Cell Proliferation; Cell Separation; Cytotoxicity, Immunologic; Flow Cytometry; Fluoresceins; Immunotherapy; Ligands; Major Histocompatibility Complex; MART-1 Antigen; Melanoma; Microscopy, Confocal; Peptides; T-Lymphocytes, Cytotoxic; Time Factors

2009
Possible role of the multidrug resistance-associated protein (MRP) in chemoresistance of human melanoma cells.
    International journal of cancer, 1997, Mar-28, Volume: 71, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antineoplastic Agents; ATP-Binding Cassette Transporters; Benzbromarone; Blotting, Northern; Cisplatin; Daunorubicin; Doxorubicin; Drug Resistance, Neoplasm; Enzyme Inhibitors; Ethylmaleimide; Etoposide; Female; Fluoresceins; Humans; Male; Melanoma; Middle Aged; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Probenecid; RNA, Messenger; Tumor Cells, Cultured; Uricosuric Agents; Vinblastine

1997